IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. DGX
10. IONQ

Go back to IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
(NASDAQ: IMNN) Delayed: 1.51 +0.08 (5.59%)
Previous Close $1.43    52 Week High $ 
Open $1.43    52 Week Low $ 
Day High $1.59    P/E N/A 
Day Low $1.43    EPS $ 
Volume 331,243